Savara (SVRA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Savara (SVRA) is Neutral.

The composite score behind that read is +0.01, weighing +0.12 of bullish evidence against -0.16 bearish.

Savara last closed at $4.92, +1.86% on the session.

Against the IVW growth benchmark the position is +1.06% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

Savara has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Savara in the 12th percentile on return on equity, where 100 is best.

Savara is classified under Health Care / Biotechnology, with a market capitalisation of $992.37M.

StockMap tracks Savara as the 133rd largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Savara ranks 91st of 381 in the group, against a group median of -0.08.